OpenAlex
PricingAboutJobs
Log inGet started
Work

Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing ≥ 10% epidermal growth factor receptor (EGFr)

HTML

Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2006.24.18_suppl.3548
Authors: J. Berlin, M. Neubauer, P. Swanson, W. G. Harker, H. Burris, J. R. Hecht, L. Navale
Institutions: Amgen (United States), University of California, Los Angeles, Vanderbilt University, Utah Cancer Specialists, Tennessee Oncology, Vanderbilt University Medical Center
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: panitumumab, metastatic colorectal cancer, epidermal growth factor receptor, anti-EGFR monoclonal antibody, refractory disease, objective response rate, progression-free survival, treatment-related adverse events, skin toxicity, ocular toxicity, irinotecan, oxaliplatin, fluoropyrimidine, duration of response, survival
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3011109864
Cites:
Cited by: 72
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security